RELIABILITY OF THE MATSON EVALUATION OF DRUG SIDE EFFECTS SCALE (MEDS)
Saved in:
MATSON, J.L., ET AL., RELIABILITY OF THE MATSON EVALUATION OF DRUG SIDE EFFECTS SCALE (MEDS). Research in Developmental Disabilities, Vol. 19, no. 6 (1998), p. 501-506.
Ref.
72486
Location:
SIIS R.775
Palabras clave:
Discapacidad intelectual, Efectos, Escalas, Evaluación, Fármacos, Psicótropos
Discapacidad intelectual, Efectos, Escalas, Evaluación, Fármacos, Psicótropos
Similar Items: RELIABILITY OF THE MATSON EVALUATION OF DRUG SIDE EFFECTS SCALE (MEDS)
- THE CONVERGENT VALIDITY OF THE MATSON EVALUATION OF SOCIAL SKILLS FOR INDIVIDUALS WITH SEVERE RETARDATION (MESSIER)
- AN EXAMINATION OF PSYCHOTROPIC MEDICATION SIDE EFFECTS: DOES TAKING A GREATER NUMBER OF PSYCHOTROPIC MEDICATIONS FROM DIFFERENT CLASSES AFFECT PRESENTATION OF SIDE EFFECTS IN ADULTS WITH ID?
- BENZODIAZEPINE BEHAVIORAL SIDE EFFECTS: REVIEW AND IMPLICATIONS FOR INDIVIDUALS WITH MENTAL RETARDATION
- ASSESSING SIDE EFFECTS OF PHARMACOTHERAPY TREATMENT OF BIPOLAR DISORDER: A 20 YEAR REVIEW OF THE LITERATURE
- THE VERBAL BEHAVIOR ASSESSMENT SCALE (VERBAS): CONSTRUCT VALIDITY, RELIABILITY, AND INTERNAL CONSISTENCY
- EVALUATING PSYCHOTROPIC DRUGS IN PEOPLE WITH MENTAL RETARDATION: WHERE ARE THE SOCIAL VALIDITY DATA?